An Israeli company has gotten the go-ahead from European authorities to manufacture a universal flu vaccine. This would obviate the need to develop a new vaccine for each flu season.

BiondVax Pharmaceuticals recently announced that it passed an intensive two-day QP GMP audit –
giving it a green light to advance clinical development of its universal flu vaccine,
M-001, in the EU. This